Correction of the tumor suppressor Salvador homolog-1 deficiency in tumors by lycorine as a new strategy in lung cancer therapy

Salvador homolog-1 (SAV1) is a tumor suppressor required for activation of the tumor-suppressive Hippo pathway and inhibition of tumorigenesis. SAV1 is defective in several cancer types. SAV1 deficiency in cells promotes tumorigenesis and cancer metastasis, and is closely associated with poor progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhe, Xiang, Shufen, Qi, Jindan, Wei, Yijun, Zhang, Mengli, Yao, Jun, Zhang, Tong, Meng, Mei, Wang, Xiaohua, Zhou, Quansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242319/
https://www.ncbi.nlm.nih.gov/pubmed/32439835
http://dx.doi.org/10.1038/s41419-020-2591-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242319/
https://www.ncbi.nlm.nih.gov/pubmed/32439835
http://dx.doi.org/10.1038/s41419-020-2591-0

Ejemplares similares